Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genetic changes in prostate cancer

N Konishi1, M Cho, K Yamamoto

  • 1Second Department of Pathology, Nara Medical University, Japan. nkonishi@nmu-gw.cc.naramed-u.ac.jp

Pathology International
|December 31, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bone marrow stromal cells attenuate mitoxantrone cytotoxicity against HL-60 leukemic cells.

Anti-cancer drugs·1992
Same author

[The resolution of D- and L-amino acids by reversed-phase high-performance liquid chromatography].

Seikagaku. The Journal of Japanese Biochemical Society·1992
Same author

[Antimutagenic substances in the Armeniacae semen and Persicae semen].

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·1992
Same author

Two sudden death cases of idiopathic ventricular tachycardia.

The Tokushima journal of experimental medicine·1992
Same author

A case of concealed WPW syndrome with three different reciprocal tachycardias due to triple AV nodal pathways.

The Tokushima journal of experimental medicine·1992
Same author

Effects of phosphate in the production of hemolysin in Vibrio parahaemolyticus.

East African medical journal·1992
Same journal

Glomerular Capillary Microaneurysms in Membranoproliferative Glomerulonephritis: A Clinicopathological Study Highlighting the Involvement of IgG3.

Pathology international·2026
Same journal

A Homology-Based Application to Diagnose Colorectal Adenoma and Early-Stage Cancer.

Pathology international·2026
Same journal

Comprehensive Profiling Reveals Sialyl-Tn Upregulation and Prognostic Value in Prostate Cancer.

Pathology international·2026
Same journal

Undifferentiated Carcinoma of the Endometrium: Morphology, Immunophenotype, and Differential Diagnoses to Avoid Diagnostic Pitfalls.

Pathology international·2026
Same journal

Significance of Positive Cerebrospinal Fluid Cytology (Leptomeningeal Metastasis) in Central Nervous System Metastasis - A Multicentre Clinicopathological Review.

Pathology international·2026
Same journal

Role of Upregulated Mucin 21 in Detached Lung Cancer Cells.

Pathology international·2026
See all related articles

Genetic alterations drive prostate cancer development. This review details specific genetic changes in prostate cancer using restriction landmark genomic scanning (RLGS) to understand disease progression and pathology.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • Tumorigenesis results from accumulated genetic alterations, but these vary by neoplasm.
  • Prostate cancer presents diverse histologies, complicating diagnosis and molecular event interpretation.
  • Analyzing genetic aberrations in prostate cancer is crucial for correlating pathology and disease natural history.

Purpose of the Study:

  • To review identified genetic alterations specific to human prostate cancer.
  • To explore novel molecular events in prostate cancer using advanced genomic techniques.
  • To correlate genetic aberrations with prostate cancer pathology and disease progression.

Main Methods:

  • Conventional mutational analyses of oncogenes and tumor suppressor genes.

Related Experiment Videos

  • Restriction landmark genomic scanning (RLGS) for comprehensive genetic alteration analysis.
  • Examination of genomic tumor DNA from multiple samples.

    • Main Results:

    • Identified specific genetic alterations peculiar to human prostate cancer.
    • Provided insights into molecular events underlying prostate cancer development.
    • Highlighted the utility of RLGS in uncovering novel genetic changes.

    Conclusions:

    • Understanding genetic alterations is key to deciphering prostate cancer's complexity.
    • RLGS is a powerful tool for detailed genomic analysis in cancer research.
    • Continued molecular investigation is vital for advancing prostate cancer diagnosis and treatment.